PromarkerD significantly outperforms current standard of care tests in predicting future kidney function decline
- Written by PR Newswire Asia - News Pronto RSS
- Study shows PromarkerD is significantly better than current standard of care tests eGFR and ACR for predicting future decline in kidney function in patients with type 2 diabetes
- PromarkerD correctly identified 84% of patients with normal kidney function that went on to experience kidney function decline that would be missed by standard of care tests...